If your child is up to 8 months old and a preterm baby born between 29 and 35 weeks’ gestational age, they may be eligible to take part in a clinical study.
The Oxford Vaccine Group, part of the University of Oxford, is taking part in a study of a new medicine to see whether its protects healthy preterm babies from RSV Infection.
Respiratory Syncytial Virus (RSV) is a virus that is present in the general population from late autumn to early spring and is the commonest cause of cold like illness in older children. However, it can cause serious lung disease in infants. Preterm infants are at high risk of having serious illness from RSV infection.
If you are interested in your child talking part, or would like more information, please read the Study Information Booklet
If you would like any further information regarding the study please contact us on:
Email email@example.com, Tel: 0186 561 1400
The Oxford Vaccine Group